Navigation Links
Scientists measure connection between the built environment and obesity in baby boomers
Date:8/11/2008

to change their lifestyles to eat better and to get more exercise -- is insufficient. Measures are also needed to improve features of the built environment, which are often modifiable (e.g., via changes in city zoning, development policies), to support people in making such changes." says Li.

ORI scientists studied the built environment characteristics (land-use mix, density of fast-food outlets, street connectivity, & public transit stations, and the presence of green & open spaces) of 120 neighborhoods in Portland, Oregon. Over 1200 residents of the neighborhoods provided the researchers information on their age, gender, education, race/ethnicity, household income, alcohol & tobacco use, general health status, Body Mass Index (BMI), and eating habits. The residents' levels of physical activity were also measured, including neighborhood walking, walking for transportation (to catch a bus), walking for household errands, and moderate or vigorous exercise. All participants were between the ages of 50 and 75.

The results showed significant associations among built-environment factors and the prevalence of overweight/obesity and various forms of physical activity in middle-aged and older adults. These findings suggest the need for public health and city planning officials to consider how modifiable neighborhood-level, built-environment characteristics can create more livable residential communities and promote active, healthy lifestyles.


'/>"/>

Contact: Kathryn Madden
kathryn@ori.org
Oregon Research Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Gladstone scientists identify single microRNA that controls blood vessel development
2. Scientists identify another piece of the weight-control puzzle
3. Scientists Create Mice Resistant to Obesity
4. Scientists Turn Skin Cells Into Motor Neurons in ALS Patients
5. Scientists race to stay ahead of the drug-taking and genetic manipulation that threatens sport
6. Scientists ID Jekyll-Hyde Protein in Lou Gehrigs Disease
7. Scientists identify how gastric reflux may trigger asthma
8. Embargoed Until Monday, July 21 at 5 p.m. EST; Scientists Figure Out How the Immune System and Brain Communicate to Control Disease
9. CSHL scientists correlate enzyme expression levels with chemotherapy drug response
10. Weizmann Institute scientists new technique gets to the root of cancer
11. NOAA and Louisiana scientists predict largest Gulf of Mexico dead zone on record
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Anesiva Stockholders Approved Merger With Arcion Therapeutics but Merger Remains Contingent on Other Closing Conditions 2Health News:Anesiva Stockholders Approved Merger With Arcion Therapeutics but Merger Remains Contingent on Other Closing Conditions 3Health News:PROVERI, Inc. Named a Top Innovator Winner 2Health News:Frost & Sullivan to Hold Web Conference on Integrated Hospital Pharmacy Information Systems - How to Maneuver towards Growth Potential 2Health News:Innovative Applications of Flow Cytometry Win U.S. and European Researchers Free Accuri C6 Flow Cytometer(R) Systems 2Health News:Innovative Applications of Flow Cytometry Win U.S. and European Researchers Free Accuri C6 Flow Cytometer(R) Systems 3Health News:Innovative Applications of Flow Cytometry Win U.S. and European Researchers Free Accuri C6 Flow Cytometer(R) Systems 4Health News:InfoZoom Launches V6.4 of its Industry Leading In-Memory Data Analysis Software 2Health News:InfoZoom Launches V6.4 of its Industry Leading In-Memory Data Analysis Software 3
Other Medicine News:Health News:New National Public Opinion Survey Reveals Important Findings on Oral Health Care Perceptions 2Health News:New National Public Opinion Survey Reveals Important Findings on Oral Health Care Perceptions 3Health News:GBH Communications, Inc. Offers Next Generation of LifeSize High Definition Video Communications and Telepresence Products 2Health News:GBH Communications, Inc. Offers Next Generation of LifeSize High Definition Video Communications and Telepresence Products 3Health News:New Study Reveals Consumers Want Greater Say in Key Food Issues 2Health News:New Study Reveals Consumers Want Greater Say in Key Food Issues 3Health News:New Study Reveals Consumers Want Greater Say in Key Food Issues 4Health News:New Study Reveals Consumers Want Greater Say in Key Food Issues 5Health News:Ms. Planet Beach International to be Hosted by Ali Landry and Lorenzo Lamas 2Health News:CPF Fundraisers Bring in Landmark Half Million Dollars in Less Than Three Weeks 2Health News:CPF Fundraisers Bring in Landmark Half Million Dollars in Less Than Three Weeks 3Health News:A Mindful Chocolate Meditation 2
Breaking Medicine Technology:Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 2Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 3Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 4Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 2Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 3Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 4Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 5Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 6Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Sigma Aldrich 28R 29 and Sangamo BioSciences Announce Major Expansion of ZFP Technology License Agreement 14347 1Sigma Aldrich 28R 29 and Sangamo BioSciences Announce Major Expansion of ZFP Technology License Agreement 14347 2Sigma Aldrich 28R 29 and Sangamo BioSciences Announce Major Expansion of ZFP Technology License Agreement 14347 3Sigma Aldrich 28R 29 and Sangamo BioSciences Announce Major Expansion of ZFP Technology License Agreement 14347 4Genome Quebec and Montreal Heart Institute Pharmacogenomics Centre Deploys Isilon IQ in Next Generation of Drug Development 5206 1Genome Quebec and Montreal Heart Institute Pharmacogenomics Centre Deploys Isilon IQ in Next Generation of Drug Development 5206 2Frost 26amp 3B Sullivan Lauds Viatronix as European Medical Imaging Emerging Company of the Year 5205 1Frost 26amp 3B Sullivan Lauds Viatronix as European Medical Imaging Emerging Company of the Year 5205 2Frost 26amp 3B Sullivan Lauds Viatronix as European Medical Imaging Emerging Company of the Year 5205 3Frost 26amp 3B Sullivan Lauds Viatronix as European Medical Imaging Emerging Company of the Year 5205 4